Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity. (Q45985707)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 June 2009

Language	Label	Description	Also known as
English	Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.	scientific article published on 2 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

Katherine Kedzierska

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

Lukasz Kedzierski

object named as

L Kedzierski

1

0 references

author name string

J M Curtis

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

publication date

2 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

136

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

833-840

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

Leishmania vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

The immune response to Leishmania: mechanisms of parasite control and evasion.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Regulation of lymph node vascular growth by dendritic cells.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

The lipophosphoglycan of Leishmania parasites

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Persistence without pathology in phosphoglycan-deficient Leishmania major.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Structure of Leishmania mexicana Phosphomannomutase Highlights Similarities with Human Isoforms

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

21 January 2018

Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica

1 reference

https://api.crossref.org/works/10.1017%2FS0031182009006301

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0031182009006301

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

release_xetme5jarvdelcvd7qbbbz3fey

1 reference

https://api.fatcat.wiki/v0/release/xetme5jarvdelcvd7qbbbz3fey

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19490731

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45985707&oldid=1838175900"